FDA inspects Dr Reddy’s R&D center

New Delhi: Dr Reddy’s Laboratories on Thursday said the US health regulator is conducting an inspection of its Hyderabad-based R&D facility. “We would like to inform you that the US Food and Drug Administration (USFDA) has commenced an inspection at our R&D facility in Bachupally, Hyderabad, and the outcome of the same will be updated and necessary disclosure will be made with the stock exchanges,” it said in a regulatory filing.